von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
about
Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogenResolution of fibrinogen deficiency in a patient with congenital afibrinogenemia after liver transplantationAdhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAKEDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA.Thrombosis in Inherited Fibrinogen Disorders.Rapid platelet accumulation leading to thrombotic occlusion.In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.Adenosine diphosphate-induced aggregation of human platelets in flow through tubes. II. Effect of shear rate, donor sex, and ADP concentrationThe role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stressDistinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIaVon Willebrand factor and von Willebrand disease.Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.Fibrin induces release of von Willebrand factor from endothelial cells.Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptorsRGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen.Glanzmann's thrombasthenia with mild von Willebrand's disease.Treatment of congenital fibrinogen deficiency: overview and recent findings.Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.von Willebrand factor and platelet function.Integrin structure and function in hemostasis and thrombosis.Congenital afibrinogenemia: from etiopathogenesis to challenging clinical management.Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin beta3.Old concepts and new developments in the study of platelet aggregation.The platelet glycoprotein IIb/IIIa-like protein in human endothelial cells promotes adhesion but not initial attachment to extracellular matrixEvaluation of platelet surface glycoproteins in patients with Glanzmann thrombasthenia: Association with bleeding symptoms.Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha.Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.Vitronectin inhibits blood platelet aggregation.The Membrane Glycoprotein IIb/IIIa Complex Mediates Deposition of Thrombin-stimulated Blood Platelets on Polystyrene Plastic Under Static Conditions.
P2860
Q28588951-07E693B2-A0E8-4947-B87D-245F9C738992Q29027960-2725289A-6AC1-4294-9C40-C79E871F7496Q30442274-784163A5-18B4-4121-94A4-35BD836D89CCQ33492095-0CAB31AB-1C48-41FD-A92A-34F53499F680Q33659450-53D6EBA5-8450-49DF-B266-5D7E868AF113Q33852077-8D952527-F202-4981-B3C4-9A44A232DA31Q33873826-4D9031C1-33A9-4953-A2FF-2D464EA2A78FQ34125159-72398DDD-F3EF-4069-B0BB-22E1460838CFQ34182746-2ABCCB7C-3894-43B7-A746-BFD8918DFA02Q34260216-BC15E26D-988F-4CF3-9CAA-07D6CECA24C2Q34530389-6A70CBD1-BED9-46A9-B834-E6910F42A714Q34549309-EB0CEA99-377B-4EFD-BBC7-8222CB7755BCQ34554656-57F5E0F0-B0C1-4FFF-9574-98DEC3AFC2E2Q34564820-5F5EE346-1BB9-4DDE-9304-FFC45C3C7452Q35577294-B78294DC-5C35-42DC-8007-D841D17C026EQ35814524-AF212B38-244A-497A-9183-4285B25D44E2Q36407213-8C70A401-0F9B-4D68-8B2D-2F534D07BEB6Q37244598-36A82A25-03F8-463A-A9DF-0655303875FAQ37388583-481BB526-444D-4D7C-98AB-D0E1BD97529DQ37393216-54B833F0-086C-4D2B-BA2E-F525823A7F21Q37711736-FEE001E3-DD90-4198-8621-51873A2A5DC1Q37711750-77B1B2E5-38FC-4456-81AA-FD656E20E83AQ38862618-8FA3427E-0973-4B2A-8DCE-4B7AB78D292CQ40656704-F854D182-024C-420A-86FB-C908E7AA64A0Q40716742-7CB54E98-9848-4C94-A4BB-A48537F8ED68Q41527357-62182D6B-738D-4355-A4CD-8A38C95F9AF4Q42689568-94A03743-B589-46F4-9DC6-2260290D882FQ42971426-266AE1B2-762E-49B2-B262-ECE3290F5D84Q45297966-E6E07572-6269-46E9-8CBA-269346BEB0C8Q47776684-9668AD6C-A4E7-4510-922A-7970891480D5Q47776991-11253F3D-D5EF-4E9D-969B-E2842DD59B99
P2860
von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
description
1986 nî lūn-bûn
@nan
1986 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
von Willebrand factor interact ...... th congenital afibrinogenemia.
@ast
von Willebrand factor interact ...... th congenital afibrinogenemia.
@en
von Willebrand factor interact ...... th congenital afibrinogenemia.
@nl
type
label
von Willebrand factor interact ...... th congenital afibrinogenemia.
@ast
von Willebrand factor interact ...... th congenital afibrinogenemia.
@en
von Willebrand factor interact ...... th congenital afibrinogenemia.
@nl
prefLabel
von Willebrand factor interact ...... th congenital afibrinogenemia.
@ast
von Willebrand factor interact ...... th congenital afibrinogenemia.
@en
von Willebrand factor interact ...... th congenital afibrinogenemia.
@nl
P2093
P2860
P356
P1476
von Willebrand factor interact ...... th congenital afibrinogenemia.
@en
P2093
A Girolami
L De Marco
T S Zimmerman
Z M Ruggeri
P2860
P304
P356
10.1172/JCI112430
P407
P577
1986-04-01T00:00:00Z